Medicare Coverage for Early Blood Screening Tests for Alzheimer’s Disease.
This Act ensures that the federal health insurance program, Medicare, will cover the costs of new, early screening tests for Alzheimer’s disease and related dementias. This means seniors and other Medicare beneficiaries will gain access to innovative blood tests capable of detecting the disease in its pre-symptomatic or early stages. These changes, aimed at enabling quicker diagnosis and intervention, are scheduled to take effect starting January 1, 2028.
Key points
Medicare coverage is expanded to include early detection screening tests for Alzheimer’s and related dementias.
Covered tests include innovative blood-based genomic sequencing and other FDA-approved methods for early detection.
The new benefit will be available to Medicare beneficiaries starting January 1, 2028.
Introduced
Citizen Poll